Introduction Dimethyl-fumarate is a recently approved drug for relapsing-remitting Multiple Sclerosis in Italy. Clinical case A 55-year-old woman started therapy with dimethyl-fumarate on June 2014; it was well-tolerated aside from moderate flushing. Starting September 2014 she noticed a progressive hair loss, that neither the dermatological examination nor clinical and medical history nor blood investigations could explain. The hair loss slowed down after two months and was followed by a hair growth back. Discussion Transient hair loss is not a reported side effect of dimethyl-fumarate therapy but by excluding any known cause we attributed it to the beginning of the new therapy.
Losavio, F. A., Lucchini, M., De Fino, C., Mirabella, M., Nociti, V., Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis, <<MULTIPLE SCLEROSIS AND RELATED DISORDERS>>, 2016; 7 (N/A): 68-69. [doi:10.1016/j.msard.2016.03.006] [http://hdl.handle.net/10807/96121]
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis
Lucchini, MatteoSecondo
;De Fino, Chiara;Mirabella, MassimilianoPenultimo
;Nociti, VivianaUltimo
2016
Abstract
Introduction Dimethyl-fumarate is a recently approved drug for relapsing-remitting Multiple Sclerosis in Italy. Clinical case A 55-year-old woman started therapy with dimethyl-fumarate on June 2014; it was well-tolerated aside from moderate flushing. Starting September 2014 she noticed a progressive hair loss, that neither the dermatological examination nor clinical and medical history nor blood investigations could explain. The hair loss slowed down after two months and was followed by a hair growth back. Discussion Transient hair loss is not a reported side effect of dimethyl-fumarate therapy but by excluding any known cause we attributed it to the beginning of the new therapy.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.